Hands-on Training to Assess Hemodynamically Significant Patent Ductus Arteriosus Using Neonatal Echocardiography Simulator

Monday, April 28, 2025

9:15am – 10:45am HST

Location: Convention Center: Kalākaua Ballroom B (Level 4)

CE: 1.5

Leader(s)

Rangasamy Ramanathan, MBBS, MD.

Professor/Division Chief, Division of Neonatology
Cedars Sinai Guerin Children's
Los Angeles, California, United States

Co-Leader(s)

Yogen Singh, MD, MA (Cantab), FRCPCH

Professor of Pediatrics, Division of Neonatology
University of California Davis Children's Hospital
Loma Linda, California, United States
Mahmood Ebrahimi, MD (he/him/his)

clinical instructor in pediatrics
Cedars Sinai Medical Center
ENCINO, California, United States
Shazia Bhombal, MD

Associate Professor
Children’s Healthcare of Atlanta/Emory University
Atlanta, Georgia, United States
BC

Belinda Chan, MD

Associate professor
University of utah, United States
MU

Merujan Uzunyan, MD (he/him/his)

Associate Professor of Pediatrics
USC
CHATSWORTH, California, United States
TW

Tai-Wei Wu, MD

Adjunct Associate Professor of Clinical Pediatrics
Keck School of Medicine, USC; Kaiser Permanente Southern California Region, United States
Piyawat Arichai, MD (he/him/his)

Neonatal-Perinatal Medicine Fellow
Pediatrics
Children's Hospital Los Angeles
Children's National Hospital
Pasadena, California, United States
GK

Golenaz Kohbodi, MD

Assistant Professor of Pediatrics
Loma Linda Children's Hospital
Loma Linda, California, United States
Sharada Gowda, MD, FAAP

Associate professor of pediatrics
Baylor College of Medicine, United States
SN

Shahab Noori, MD, MS CBTI, RDCS

Professor of Pediatrics
Pediatrics, Division of Neonatology
CHLA, USC
Los Angeles, California, United States
Caroline Yeon-Kyeong Noh, MD MSEpi

Assistant Professor
Children's Hospital Los Angeles / USC Keck School of Medicine
Los Angeles, California, United States
TA

Timur Azhibekov, MD, MS (he/him/his)

Staff Neonatologist
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s):

Rangasamy Ramanathan, MBBS, MD.: Chiesi, USA (Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); Medtronics (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Neotech Products, Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); Oak Hill Bio (Ongoing) (Products/Services: Contractor including contracted research, Research Support including clinical trials & the principal or named investigator)

Yogen Singh, MD, MA (Cantab), FRCPCH: Chiesi (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); GE (Ongoing) (Products/Services: Consultant)

Mahmood Ebrahimi, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Shazia Bhombal, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Belinda Chan, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Merujan Uzunyan, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Tai-Wei Wu, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Piyawat Arichai, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Golenaz Adeli Kohbodi, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sharada H. Gowda, MD, FAAP: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Shahab Noori, MD, MS CBTI, RDCS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Caroline Yeon-Kyeong Y. Noh, MD MSEpi: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Timur Azhibekov, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Workshop Description: Targeted Neonatal Echocardiography (TnECHO) is increasingly recognized as a useful tool in assessment of hemodynamic status and management of cardiovascular compromise in neonatal and pediatric and Cardiac intensive care units. However, the widespread use of TnECHO has been hampered by several obstacles including the limited opportunity to learn the skills. In this workshop, we will have 15 mannequin-based haptic echocardiographic simulators capable of simulating a full range of neonatal two-dimensional, color flow Doppler, spectral Doppler and M-mode echocardiograms. The main simulator screen displays the full range of all the standard echocardiographic views and the side screen displays the position and motion of the cutting planes through a three-dimensional heart model. The system includes a software module to perform hemodynamic measurements from specific video clip images. In this workshop, the learner will be introduced to the 17 essential echocardiographic views with a hands-on approach using the simulator. Learners will practice echocardiographic views in a preterm infant with patent ductus arteriosus through high parasternal short axis and or ductal cut to estimate the size and shunt direction, Left Atrium (LA) to Aortic root (Ao) ratio through parasternal long axis view, and flow pattern in the superior mesenteric artery and or celiac artery through subcostal infradiaphragmatic, longitudinal aorta view. The workshop comprises a 30-minute review of the standard views, and 60-minutes hands-on practice sessions. Each simulator will be used by 4 learners and 60 learners can participate. Leaders and Co-Leaders have extensive experience in using TnECHO in their daily practice.

Learning Objectives:

Upon completion of the workshop, learners will be to: Know the standard echocardiographic views
Able to assess PDA size, shunt direction and determine the shunt pattern
Able to assess the hemodynamic significance by evaluating LA/Ao ratio, and flow reversal in the descending aorta, superior mesenteric artery and celiac artery